Novel Drug Combo Improves Breast Cancer Survival

AP — Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other medicines, doctors reported Friday. It was the first big test of combining Herceptin and Tykerb. In a study of 300 patients, women receiving both drugs lived nearly five months longer than those given Tykerb alone. Read Article

Tags: disease & medicine, gender & sexuality, pharmaceuticals